Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II

Epithelial ovarian carcinoma (EOC) is the most prevalent and lethal form of ovarian cancer. The low five-year overall survival after EOC diagnosis indicates an urgent need for more effective ways to control this disease. Anti-Müllerian hormone receptor 2 (AMHR2) is an ovarian protein overexpressed i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Mazumder, Suparna, Swank, Valerie, Komar, Anton A., Johnson, Justin M., Tuohy, Vincent K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2020
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7244012/
https://ncbi.nlm.nih.gov/pubmed/32499873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27585
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak